Company: PTHS
Filing Date: 2025-05-09
Form Type: PREM14C
Source: 0001140361-25-018219
Chunk: 26

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-05-09
Form: PREM14C
Chunk 26
---
 board of directors adopted a resolution approving the Name Change Charter Amendment to change the name of the corporation from “Channel Therapeutics Corporation” to “Pelthos Therapeutics Inc.” upon the consummation of the Transactions. Following the delivery of the Written Consent and upon filing of the Name Change Charter Amendment with the Secretary of State of the State of Nevada, the name of Channel will change to “Pelthos Therapeutics Inc.” A copy of the Name Change Charter Amendment is attached as Annex C to this information statement.

#### The Amended and Restated 2023 Plan
On April 11, 2025, the Channel board of directors adopted a resolution approving the Amended and Restated 2023 Plan. Following the delivery of the Written Consent, the Amended and Restated 2023 Plan became effective as of the same date. Stockholder approval of the Amended and Restated 2023 Plan is also required pursuant to

<div align='center'>11</div>

#### TABLE OF CONTENTS
Section 711 of the NYSE American Guide, which requires stockholder approval with respect to the material amendment to a stock option or purchase plan or other equity compensation arrangement pursuant to which options or stock may be acquired by officers, directors, employees, or consultants, regardless of whether or not such authorization is required by law or by the company’s charter, with limited exceptions. A copy of the Amended and Restated 2023 Plan is attached as Annex D to this information statement.

#### The Reverse Stock Split
On April 11, 2025, the Channel board of directors adopted a resolution approving the Reverse Stock Split Charter Amendment to effect a Reverse Stock Split of all outstanding shares of Channel common stock, by a ratio in the range of one-for five to one-for-twenty-five, to be determined in the Board’s discretion, only to the extent needed to meet the listing requirements for listing the shares of the combined company on The NYSE American. Stockholder approval of the Reverse Stock Split is required pursuant to Section 78.2055 of the NRS, which requires stockholder approval with respect to a decrease in the number of issued and outstanding shares of a class or series held by Channel stockholders without correspondingly decreasing the number of authorized shares of the same class or series.

#### Additional Information
You can find more information about Channel in the periodic reports and other information we file with the SEC. The information is available at the website maintained by the SEC at www.sec.gov.

For more information, see the section